We are live on ! Find out more
CDLX icon

Cardlytics

63 hedge funds and large institutions have $272M invested in Cardlytics in 2019 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 11 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 11

57% more capital invested

Capital invested by funds: $173M → $272M (+$98.7M)

22% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 9

3% more funds holding

Funds holding: 6163 (+2)

0% more funds holding in top 10

Funds holding in top 10: 22 (0)

0.16% less ownership

Funds ownership: 7.45%7.29% (-0.16%)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $3.15M

Holders
63
Holders Change
+2
Holders Change %
+3.28%
% of All Funds
1.36%
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.04%
New
11
Increased
31
Reduced
11
Closed
9
Calls
Puts
$3.15M
Net Calls
-$3.15M
Net Calls Change
-$1.49M

CDLX Hedge Fund Activity: Q1 2019 in Review

63 of the 4,633 institutional investors tracked by Wall St. Rank reported a position in Cardlytics (CDLX) for Q1 2019, worth a combined $272M — up 57% from $173M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CDLX positions and 9 closed out — a net gain of 2 holders — while 31 added to existing stakes and 11 trimmed.

The largest buyer was Hudson Bay Capital Management, opening a new position worth an estimated $4.03M. The largest seller was Canaan Partners VIII, cutting an estimated $12.2M.

  • 63 institutional investors held Cardlytics (CDLX) as of Q1 2019, up from 61 in Q4 2018.
  • Funds reported $272M of Cardlytics stock for Q1 2019, up 57% quarter-over-quarter.
  • 11 funds opened new Cardlytics positions in Q1 2019 and 9 closed out, a net change of +2 holders.
  • The largest Cardlytics buyer in Q1 2019 was Hudson Bay Capital Management, an estimated $4.03M added.
  • The largest Cardlytics seller in Q1 2019 was Canaan Partners VIII, an estimated $12.2M sold.

Based on aggregated 13F filings for Q1 2019.